Bolton Securities’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.6K Hold
300
– – ﹤0.01% 1521
2026
Q2
$33.3K Hold
300
– – ﹤0.01% 1462
2026
Q1
$26.1K Hold
300
– – ﹤0.01% 1387
2025
Q4
$32.1K Hold
300
– – ﹤0.01% 1310
2025
Q3
$30.3K Hold
300
– – ﹤0.01% 1284
2025
Q2
$19K Hold
300
– – ﹤0.01% 1346
2025
Q1
$15.9K Buy
+300
New +$16.6K ﹤0.01% 1335

Other funds holding RYTM

Bolton Securities's RYTM Position: Q3 2026 in Review

Bolton Securities held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 300 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.

Bolton Securities first reported a position in RYTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $33.3K in Q2 2026. 328 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Bolton Securities held 300 shares of Rhythm Pharmaceuticals worth $28.6K as of Q3 2026.
  • Bolton Securities left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #1521 holding.
  • Bolton Securities first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Bolton Securities's Rhythm Pharmaceuticals position peaked at $33.3K in Q2 2026.
  • 328 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.